Fine mapping of type 1 diabetes susceptibility loci and evidence for colocalization of causal variants with lymphoid gene enhancers
Suna Önengüt-Gümüşcü(University of Virginia), Stephen S. Rich(Wellcome Sanger Institute), Chris Wallace(University of Cambridge), Hui Guo(Henan University of Traditional Chinese Medicine), Nick J. Cooper(National Institute for Health and Care Research), Jessica Bonnie(University of Virginia), Oliver S. Burren(AstraZeneca (United Kingdom)), Jeffrey C. Barrett(Centre for Human Genetics), Mary D Fortune(National Institute for Health and Care Research), Michał Szpak(University of Virginia), Ellen Schofield(National Institute for Health and Care Research), Neil Walker, Aaron R. Quinlan(University of Virginia Health System), Patrick Concannon(University of Florida), Emily Farber(University of Virginia), Panos Deloukas(Queen Mary University of London), Anshul Kundaje(Stanford University), Wei‐Min Chen(Michigan United), Premanand Achuthan(National Institute for Health and Care Research), Lucas D. Ward(Broad Institute), Jason D. Cooper(National Institute for Health and Care Research), M Kellis(Baylor College of Medicine), Helen Stevens(National Institute for Health and Care Research), John A. Todd(University of Cambridge), Mark Daly(Harvard University), Josyf C. Mychaleckyj(University of Virginia)
Cited by 744
Related Papers
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
|Nature|2007|9.6k
Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations
|Nature Genetics|2015|2.7k
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci
|Nature Genetics|2010|2.6k
Learning Important Features Through Propagating Activation Differences
|arXiv (Cornell University)|2017|2.4k